+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Remote Patient Monitoring Systems - Global Strategic Business Report

  • PDF Icon

    Report

  • 442 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5968957
The global market for Remote Patient Monitoring Systems was valued at US$3.1 Billion in 2024 and is projected to reach US$9.1 Billion by 2030, growing at a CAGR of 19.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Remote Patient Monitoring Systems Market - Key Trends and Drivers Summarized

Several factors are driving the growth of RPM technology. Enhanced data analytics and AI integration improve patient monitoring accuracy, enabling predictive healthcare interventions. Improvements in connectivity solutions, such as 5G, ensure reliable data transmission from RPM devices to healthcare providers. There's also a significant increase in consumer health awareness, which has boosted demand for health monitoring devices providing real-time health metrics feedback. The popularity of wearable technologies has normalized continuous health tracking, further aiding RPM acceptance. Supportive regulatory frameworks and expanded reimbursement policies by insurance providers, including Medicare and Medicaid, are making RPM services more accessible and affordable. Additionally, patient demand for remote care options and healthcare providers' adoption of RPM for operational efficiency highlight the shift towards more integrated, technology-driven, and patient-centered healthcare solutions. These factors collectively enhance the adoption and effectiveness of RPM systems, reflecting an ongoing transformation in healthcare management practices.

The regulatory landscape for RPM has evolved rapidly, particularly spurred by the needs highlighted during the COVID-19 pandemic. Changes by entities like the Centers for Medicare and Medicaid Services (CMS), which introduced new policies and waivers to broaden RPM usage, have made these systems more accessible and applicable across various healthcare settings. Looking forward, the integration of advanced technologies and a growing recognition of the benefits of RPM point to a promising future. This is evidenced by the increasing adoption of RPM by health systems to manage complex cases remotely, thus reducing pressure on physical healthcare facilities. Continued advancements in technology and additional funding are enhancing the capabilities and efficiency of RPM devices, ensuring that remote monitoring remains a foundational aspect of modern healthcare delivery.

Remote Patient Monitoring (RPM) systems are increasingly critical in healthcare, providing vital services for the management of chronic diseases like diabetes and hypertension and enhancing care delivery. Utilizing devices such as blood pressure monitors, blood glucose meters, and advanced wearables like smartwatches, RPM systems allow continuous collection of health data, which healthcare providers use to monitor patients and adjust treatment plans accordingly. Research has highlighted the benefits of RPM, including reducing hospital stay lengths and improving the management of chronic diseases by facilitating timely adjustments in treatment. Especially evident during the pandemic, RPM proved crucial for monitoring patients remotely, alleviating hospital burdens, and has been effective in hospital-at-home programs, which deliver hospital-level care to patients at home, thereby reducing emergency visits and hospitalizations.

Report Scope

The report analyzes the Remote Patient Monitoring Systems market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below.

Segments

Product Type (Special Monitors, Vital Sign Monitors); Application (Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder, Other Applications); End-Use (Hospital Based Patients, Ambulatory Patients, Home Healthcare).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Special Monitors segment, which is expected to reach US$7.2 Billion by 2030 with a CAGR of a 18.9%. The Vital Sign Monitors segment is also set to grow at 22.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $874.4 Million in 2024, and China, forecasted to grow at an impressive 18.6% CAGR to reach $1.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Remote Patient Monitoring Systems Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Remote Patient Monitoring Systems Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Remote Patient Monitoring Systems Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Biotronik SE & Co. KG, F. Hoffmann-La Roche AG, Intel Corporation, Johnson & Johnson, Koninklijke Philips NV and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 162 companies featured in this Remote Patient Monitoring Systems market report include:

  • Biotronik SE & Co. KG
  • F. Hoffmann-La Roche AG
  • Intel Corporation
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic of Canada Ltd.
  • Philips Healthcare
  • Robert Bosch GmbH
  • Welch Allyn, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Remote Patient Monitoring Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Demand for Telehealth and Remote Healthcare Solutions
  • Growth of the Aging Population and Chronic Disease Management
  • Advancements in Remote Monitoring Technologies and Wearable Devices
  • Rising Adoption of Remote Patient Monitoring in Post-Acute Care
  • Impact of COVID-19 Pandemic on Healthcare Delivery and Remote Monitoring
  • Government Regulations and Standards for Telehealth and Remote Monitoring
  • Expansion of Remote Monitoring Applications in Home Healthcare
  • Development of Integrated and Real-Time Health Monitoring Platforms
  • Role of Remote Monitoring in Enhancing Patient Outcomes and Healthcare Efficiency
  • Market Penetration of Remote Monitoring in Rural and Underserved Areas
  • Influence of Technological Innovations on Data Accuracy and Connectivity
  • Growth of Remote Monitoring Applications in Chronic Disease Management
  • Challenges Related to Data Security and Patient Privacy Concerns
  • Emerging Markets and Growth Opportunities in Developing Regions
  • Future Trends and Innovations in Remote Patient Monitoring Systems and Healthcare Delivery
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Vital Sign Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 2: World Historic Review for Vital Sign Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 3: World 15-Year Perspective for Vital Sign Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Special Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 5: World Historic Review for Special Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 6: World 15-Year Perspective for Special Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 8: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 9: World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 11: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 12: World 15-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 14: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 15: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Sleep Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 17: World Historic Review for Sleep Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 18: World 15-Year Perspective for Sleep Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 21: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Hospital based Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 23: World Historic Review for Hospital based Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 24: World 15-Year Perspective for Hospital based Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Ambulatory Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 26: World Historic Review for Ambulatory Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 27: World 15-Year Perspective for Ambulatory Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 29: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 30: World 15-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 31: World Recent Past, Current & Future Analysis for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 32: World Historic Review for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 33: World 15-Year Perspective for Hypertension by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 34: World Remote Patient Monitoring Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • Table 35: World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 36: World Historic Review for Remote Patient Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 37: World 15-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Biotronik SE & Co. KG
  • F. Hoffmann-La Roche AG
  • Intel Corporation
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic of Canada Ltd.
  • Philips Healthcare
  • Robert Bosch GmbH
  • Welch Allyn, Inc.

Table Information